Incerti Carlo 4
4 · Dyne Therapeutics, Inc. · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Incerti Carlo
Director
Transactions
- Award
Stock option (right to buy)
2025-05-30+35,000→ 35,000 totalExercise: $11.96Exp: 2035-05-29→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option was granted on May 30, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 30, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service.